Biomedical Engineering Reference
In-Depth Information
88. Maheshwari, A.; Han, S.; Mahato, R. I.; Kim, S. W. Biodegradable Polymer-based Interleu-
kin-12 gene Delivery: Role of Induced Cytokines, Tumor Infiltrating Cells and Nitric Oxide in
Anti-Tumor Activity.
Gene Ther.
2002,
9,
1075-1084.
89. Luo, D.; Woodrow-Mumford, K.; Belcheva, N.; Saltzman, W. M. Controlled DNA Delivery
Systems.
Pharm. Res.
1999,
16,
1300-1308.
90. Labhasetwar, V.; Bonadio, J.; Goldstein, S. A.; Levy, R. J. Gene Transfection Using Biode-
gradable Nanospheres: Results in Tissue Culture and a Rat Osteotomy Mode.
Colloids Surf.
Biointerfaces
1999,
16,
281-290.
91. Panyam, J.; Zhou, W. Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. Rapid Endo-lysosomal
Escape of Poly(DL-lactide-
co
-glycolide) Nanoparticles: Implications for Drug and Gene
Delivery.
FASEB
2002,
16,
1217-1226.
92. Cailleau, R.; Young, R.; Olive, M.; Reeves, W. J. Breast Tumor Cell Lines from Pleural Effu-
sions.
J. Natl. Cancer Inst.
1974,
53,
661-674.
93. Runnebaum, I. B.; Nagarajan, M.; Bowman, M.; Soto, D.; Sukumar, S. Mutations in p53 as
Potential Molecular Markers for Human Breast Cancer.
Proc. Natl. Acad. Sci. U.S.A.
1991,
88,
10657-10661.
94. Erbacher, P.; Zou, S.; Bettinger, T.; Steffan, A. M.; Remy, J. S. Chitosan-based Vector/DNA
Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability.
Pharm.
Res.
1998,
15,
1332-1339.
95. Klippstein, R.; Pozo, D. Nanotechnology-based Manipulation of Dendritic Cells for Enhanced
Immunotherapy Strategies.
Nanomed. Nanotechnol. Biol. Med.
2010,
6,
523-529.
96. Maldonaro-Lopez, R.; Moser, M. Dendritic Cell Subsets and the Regulation of Th1/Th2
Responses.
Semin. Immunol.
2001,
13,
275-282.
97. Guermonprez, P.; Valladeau, J.; Zitvogel, L.; Thery, C.; Amigorena, S. Antigen Presentation
and T cell Stimulation by Dendritic Cells.
Annu. Rev. Immunol.
2002,
20,
621-667.
98. Banchereau, J.; Steinman, R. M. Dendritic Cells and the Control of Immunity.
Nature
1998,
392,
245-252.
99. Banchereau, J.; Palucka, A. K. Dendritic Cells as therapeutic Vaccines Against Cancer.
Nat.
Rev. Immunol.
2005,
5,
296-306.
100. Hori, M.; Onishi, H.; Machida, Y. Evaluation of Eudragit-coated Chitosan Microparticles as
an Oral Immune Delivery System.
Int. J. Pharm.
2005,
297,
223-234.
101. Oppenheimer, J.; A., J.; Nelson, H. S. Safety and Efficacy Of Oral Immunotherapy with stan-
dardized Cat Extract.
J. Allergy Clin. Immunol.
1994,
93,
61-67.
102. Van Deusen, M. A.; Angelini, B. L.; Cordoro, K. M.; Seiler, B. A.; Wood, L.; Skoner, D. P.
Efficacy and Safety of oral Immunotherapy with short Ragweed Extract.
Ann. Allergy Asthma
Immunol.
1997,
78,
753-780.
103. Mosbech, H.; Dreborg, S.; Madsen, F.; Ohlsson, H.; Stahl Skov, P.; Taudorf, E., et al. High
Dose Grass Pollen Tablets used for Hyposensitization in Hay Fever Patients. A One-year Dou-
ble Blind Placebo-controlled Study.
Allergy
1987,
42,
451-455.
104. Moller, C.; Dreborg, S.; Lanner, A.; Bjorksten, B. Oral Immunotherapy of Children with Rhino-
conjunctivitis due to Birch Pollen Allergy. A Double Blind Study.
Allergy
1986,
41,
271-279.
105. Gomez, S.; Gamazo, C.; San Roman, B.; Ferrer, M.; Sanz, M. L.; Irache, J. M. Gantrez AN
Nanoparticles as an Adjuvant for Oral Immunotherapy with Allergens.
Vaccine
2007,
25,
5263-5271.
106. Petrovsky, N.; Aguilar, J. C. Vaccine Adjuvants: Current State and Future Trends.
Immunol
Cell Biol.
2004,
82,
488-496.
107. Sanders, M. T.; Brown, L. E.; Deliyannis, G.; Pearse, M. J. ISCOM-based Vaccines: The Sec-
ond Decade.
Immunol. Cell. Biol.
2005,
83,
119-128.
